Skip to content

BioRestorative Therapies, Inc.

Public company
Headquarters
MELVILLE, New York
Ticker
BRTX
CIK
0001505497

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

7
4 appointments, 3 departures

Last event

Oct 9, 2026
Executive appointmentClass I director appointed: Donald J. Currie

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
Class I directorDonald J. CurrieOct 9, 2026Appointed
directorKatharyn FieldOct 9, 2026Departed
Vice President of Research and DevelopmentSilvaSep 11, 2026Departed
member of the BoardKatharyn FieldSep 2, 2026Departed
CEOMika GrassoSep 2, 2026Appointed
Chair of the Audit CommitteeSteven BrownSep 2, 2026Appointed
CFOAnna SkowronSep 2, 2026Appointed

Related companies

Same industry and state, with recent events.

  1. Executive appointment

    Class I director appointed: Donald J. Currie

    Donald J. Currie was named Class I director of BioRestorative Therapies, Inc., effective October 7, 2026. Donald J. Currie succeeds Katharyn Field. The company reported the change in an 8-K that cites Item 5.02.

    Role: Class I director

    Source: SEC 8-K, filed Oct 9, 2026

  2. Executive departure

    director departs: Katharyn Field

    Katharyn Field, director of BioRestorative Therapies, Inc., resigns the role, effective August 31, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: director

    Source: SEC 8-K, filed Oct 9, 2026

  3. Executive departure

    Vice President of Research and Development departs: Silva

    Silva, Vice President of Research and Development of BioRestorative Therapies, Inc., resigns the role, effective September 4, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Vice President of Research and Development

    Source: SEC 8-K, filed Sep 11, 2026

  4. Executive departure

    member of the Board departs: Katharyn Field

    Katharyn Field, member of the Board of BioRestorative Therapies, Inc., resigns the role, effective August 31, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: member of the Board

    Source: SEC 8-K, filed Sep 2, 2026

  5. Executive appointment

    CEO appointed: Mika Grasso

    Mika Grasso was named Interim Chief Executive Officer of BioRestorative Therapies, Inc., effective August 26, 2026. Mika Grasso succeeds Katharyn Field. The company reported the change in an 8-K that cites Item 5.02.

    Role: Interim Chief Executive Officer

    Source: SEC 8-K, filed Sep 2, 2026

  6. Executive appointment

    Chair of the Audit Committee appointed: Steven Brown

    Steven Brown was named Chair of the Audit Committee of BioRestorative Therapies, Inc., effective August 26, 2026. Steven Brown succeeds Mika Grasso. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chair of the Audit Committee

    Source: SEC 8-K, filed Sep 2, 2026

  7. Executive appointment

    CFO appointed: Anna Skowron

    Anna Skowron was named Chief Financial Officer of BioRestorative Therapies, Inc., effective August 27, 2026. Anna Skowron succeeds Katharyn Field. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Financial Officer

    Source: SEC 8-K, filed Sep 2, 2026

Last verified Nov 8, 2026